Addiction Treatment Markets: Snapshot 

Addiction treatment is intended to help addicted individuals from compulsive seeking.  Drug abuse and addiction treatments are provided in several different settings by using a number of behavioral and pharmacological approaches. The global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 and is anticipated to expand at a CAGR of over 6.0% from 2017 to 2025 to reach value of approximately US$ 7.0 Bn by 2025. Favorable reimbursements for smoking cessation therapy, growing abuse of prescription drugs, and rise in government initiatives to raise awareness about drug addiction are some factors driving the addiction treatment market from 2017 to 2025.

Addiction is a growing concerns across the globe. According to the 2015 National Survey on Drug Use and Health (NSDUH), 15.1 million adults aged 18 year and above had alcohol use disorder, which included nearly 9.8 million men. About 1.3 million adults received treatment for AUD at a specialized facility in 2015. Over 16 million people in the U.S. are living with a diseases caused by smoking. According to CDC survey, tobacco use causes nearly 6 million deaths globally each year. Current trends indicate that tobacco use is likely to cause more than 8 million deaths annually by 2030. Drug abuse treatment providers and manufacturers of treatment products are focusing on raising awareness among people and drug store owners about adverse effects of drug abuse and importance of abuse treatment to increase the customer pool. Moreover, companies are offering training for identification of potential drug abusers and alcohol abusers and use of drug abuse testing to law enforcement agencies. Awareness through television advertisements, information brochures, newspapers, and other media have proved to be effective in curbing substance abuse crisis.

addiction treatment market

The global addiction treatment market has been segmented based on of treatment type, drug type, treatment centers, distribution channel, and geography. In terms of treatment type, tobacco/nicotine addiction treatment segment is projected to dominate the market and is expected to continue this trend during the forecast period followed by the opioid addiction treatment segment. Rise in demand for nicotine gum in developing markets is likely to propel the segment. Nicotine gum is fast-acting, relatively less expensive, and can be consumed as per user’s choice, these advantages are expected to propel the segment. Based on drug type, nicotine replacement products was the leading revenue generating segment in 2016 and it is likely to continue its dominance during the forecast period. In terms of treatment centers, outpatient treatment center segment is likely to gain market share during the forecast period as it cost lesser than residential or inpatient treatment centers and can be suitable for those who are unable to take extended leaves from work or personal obligations. Based on distribution channels, hospital pharmacies was the leading distribution channel in 2016 and is likely to account for dominant share of the market during the forecast period.

Geographically, North America accounted for a substantial share of the global cardiovascular drugs market in 2016. This is due to rise in the number of smokers in the U.S. has increased concerns regarding health risks for both smokers and passive smokers. The market in Asia Pacific is projected to gain market share during the forecast period and is likely to generate considerable revenue in the near future. Initiatives by local governments to attain self-sufficiency in manufacturing pharmaceuticals and incentives for the production of generics in countries such as Brazil, South Africa, and Saudi Arabia are likely to boost the market in Latin America and Middle East & Africa.

Key companies operating in the global addiction treatment market and profiled in the report include Cipla Ltd., Allergan plc, Alkermes plc, Pfizer Inc., Orexo AB, GlaxoSmithKiline plc, Purdue Pharma L.P, Mallinckrodt, and Reckitt Benckiser. These players adopt organic and inorganic growth strategies to expand their product offerings, strengthen their geographical reach, increase customer base, research & development activity, and garner market share. For instance, in September 2015, the Purdue Pharma L.P. collaborated with Rhodes Pharmaceuticals for the development of methylphenidate extended-release tablets for adults.

Addiction Treatment Market: Overview

This report on the addiction treatment market analyzes the current and future scenario of the global market. Rise in awareness initiatives by different drug manufacturers and government bodies and increase in abuse of prescription drugs are expected to drive the global addiction treatment market during the forecast period.

The global addiction treatment market report comprises a detailed and elaborate executive summary, which includes market snapshot that provides information about the various segments. It also provides information and data analysis of the country’s market with respect to the segments based on treatment type, drug type, treatment center, and distribution channel. An elaborated qualitative analysis of drivers and trends has been provided in the market overview section. This section also provides market attractiveness analysis in terms of country, thus presenting a thorough analysis of the overall competitive scenario in the global addiction treatment market.

Based on treatment centers, the global addiction treatment market has been classified into alcohol addiction treatment, tobacco/nicotine addiction treatment, opioid addiction treatment, and other substance addiction treatment. The segments have been analyzed based on awareness of addiction treatment, actual percentage accessing different insurance policies for treatment, and medical scenarios. The market size and forecast for each of these segments have been provided for the period from 2017 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on drug type, the market has been segmented into bupropion, varenicline, acamprosate, disulfiram, naltrexone, methadone, buprenorphine, nicotine replacement products, and others. In term of treatment centers, the market has been segmented into outpatient treatment centers, residential treatment centers, and inpatient treatment centers. The segments have been extensively analyzed based on drugs and products used in the treatment of addiction, centers that have been widely used for treatment and medical reimbursement. The market size and forecast in terms of value (US$ Mn) for each segment have been provided for the period from 2015 to 2025. The report also provides compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

In terms of distribution channels, the addiction treatment market has been segmented into hospital pharmacy, medical stores, and others. The distribution channels segmentation has been done on the basis of purchase of drugs which is prescribed for addiction treatment.

Geographically, the global addiction treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

The report also profiles major players in the global addiction treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Key players operating in the global addiction treatment market are Cipla Ltd., Allergan plc, Alkermes plc, Pfizer Inc., Orexo AB, GlaxoSmithKiline plc, Purdue Pharma L.P, Mallinckrodt, and Reckitt Benckiser (Indivior PLC).

The global addiction treatment market is segmented as follows:

Global Addiction Treatment Market, by Treatment Type

  • Alcohol Addiction Treatment
  • Tobacco / Nicotine Addiction Treatment
  • Opioid Addiction Treatment
  • Other Substance Addiction Treatment

Global Addiction Treatment Market, by Drug Type

  • Bupropion
  • Varenicline
  • Acamprosate
  • Disulfiram
  • Naltrexone
  • Methadone
  • Buprenorphine
  • Nicotine replacement products
  • Others surgical

Global Addiction Treatment Market, by Treatment Center

  • Outpatient Treatment Centers
  • Residential Treatment Centers
  • Inpatient Treatment Centers

Global Addiction Treatment Market, by Distribution Channel

  • Hospital Pharmacies
  • Medical Stores
  • Others

Global Addiction Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa (MEA)
    • South Africa
    • GCC Countries
    • Israel
    • Rest of MEA
.